Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1954 1
1955 4
1956 1
1957 2
1958 3
1959 2
1960 1
1961 3
1962 3
1963 5
1964 6
1965 8
1966 5
1967 6
1968 8
1969 12
1970 7
1971 12
1972 17
1973 23
1974 28
1975 20
1976 17
1977 19
1978 26
1979 19
1980 33
1981 23
1982 30
1983 35
1984 45
1985 56
1986 71
1987 75
1988 77
1989 105
1990 83
1991 80
1992 99
1993 67
1994 70
1995 86
1996 88
1997 115
1998 84
1999 90
2000 86
2001 104
2002 118
2003 103
2004 108
2005 124
2006 129
2007 137
2008 127
2009 148
2010 129
2011 131
2012 154
2013 135
2014 161
2015 176
2016 200
2017 256
2018 276
2019 283
2020 268
2021 304
2022 312
2023 274
2024 133

Text availability

Article attribute

Article type

Publication date

Search Results

5,485 results

Results by year

Filters applied: . Clear all
Page 1
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T. Akiyama T, et al. Among authors: yamashita k. Cancer Res. 2023 Mar 2;83(5):753-770. doi: 10.1158/0008-5472.CAN-22-1890. Cancer Res. 2023. PMID: 36543251
Stability Study of mRNA-Lipid Nanoparticles Exposed to Various Conditions Based on the Evaluation between Physicochemical Properties and Their Relation with Protein Expression Ability.
Kamiya M, Matsumoto M, Yamashita K, Izumi T, Kawaguchi M, Mizukami S, Tsurumaru M, Mukai H, Kawakami S. Kamiya M, et al. Among authors: yamashita k. Pharmaceutics. 2022 Oct 31;14(11):2357. doi: 10.3390/pharmaceutics14112357. Pharmaceutics. 2022. PMID: 36365175 Free PMC article.
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J; CKD Prognosis Consortium. Matsushita K, et al. Among authors: yamashita k. Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25. doi: 10.1016/S2213-8587(15)00040-6. Epub 2015 May 28. Lancet Diabetes Endocrinol. 2015. PMID: 26028594 Free PMC article.
Paradigm shift in myocarditis treatment.
Yakhshimurodov U, Yamashita K, Kawamura T, Kawamura M, Miyagawa S. Yakhshimurodov U, et al. Among authors: yamashita k. J Cardiol. 2024 Mar;83(3):201-210. doi: 10.1016/j.jjcc.2023.08.009. Epub 2023 Aug 18. J Cardiol. 2024. PMID: 37597837 Review.
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer.
Nose Y, Saito T, Yamamoto K, Yamashita K, Tanaka K, Yamamoto K, Makino T, Takahashi T, Kawashima A, Haruna M, Hirata M, Ueyama A, Iwahori K, Satoh T, Kurokawa Y, Eguchi H, Doki Y, Wada H. Nose Y, et al. Among authors: yamashita k. Cancer Immunol Immunother. 2023 Jan;72(1):169-181. doi: 10.1007/s00262-022-03240-2. Epub 2022 Jul 1. Cancer Immunol Immunother. 2023. PMID: 35776160 Free PMC article.
Therapeutic Advances in the Treatment of Gastroesophageal Cancers.
Li JJ, Rogers JE, Yamashita K, Waters RE, Blum Murphy M, Ajani JA. Li JJ, et al. Among authors: yamashita k. Biomolecules. 2023 May 6;13(5):796. doi: 10.3390/biom13050796. Biomolecules. 2023. PMID: 37238666 Free PMC article. Review.
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
Kameda T, Shide K, Tahira Y, Sekine M, Sato S, Ishizaki J, Takeuchi M, Akizuki K, Kamiunten A, Shimoda H, Toyama T, Maeda K, Yamashita K, Kawano N, Kawano H, Hidaka T, Yamaguchi H, Kubuki Y, Kitanaka A, Matsuoka H, Shimoda K. Kameda T, et al. Among authors: yamashita k. Viruses. 2022 Mar 29;14(4):710. doi: 10.3390/v14040710. Viruses. 2022. PMID: 35458440 Free PMC article.
5,485 results